GB0906977D0 - Drug delivery - Google Patents

Drug delivery

Info

Publication number
GB0906977D0
GB0906977D0 GBGB0906977.4A GB0906977A GB0906977D0 GB 0906977 D0 GB0906977 D0 GB 0906977D0 GB 0906977 A GB0906977 A GB 0906977A GB 0906977 D0 GB0906977 D0 GB 0906977D0
Authority
GB
United Kingdom
Prior art keywords
drug delivery
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0906977.4A
Other versions
GB2469792A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LondonPharma Ltd
Original Assignee
ROSS CALVIN J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROSS CALVIN J filed Critical ROSS CALVIN J
Priority to GB0906977A priority Critical patent/GB2469792A/en
Publication of GB0906977D0 publication Critical patent/GB0906977D0/en
Priority to JP2012506583A priority patent/JP2012524771A/en
Priority to BRPI1013539A priority patent/BRPI1013539A2/en
Priority to GB1006818.7A priority patent/GB2469754B/en
Priority to RU2011139638/15A priority patent/RU2011139638A/en
Priority to CN2010800179717A priority patent/CN102458358A/en
Priority to EP10715336A priority patent/EP2421503A1/en
Priority to US13/265,825 priority patent/US20120058158A1/en
Priority to AU2010240653A priority patent/AU2010240653A1/en
Priority to PCT/GB2010/050671 priority patent/WO2010122355A1/en
Priority to MX2011010835A priority patent/MX2011010835A/en
Priority to SG2011073939A priority patent/SG175160A1/en
Priority to NZ595467A priority patent/NZ595467A/en
Priority to CA2756879A priority patent/CA2756879A1/en
Priority to MYPI2011005079A priority patent/MY167918A/en
Publication of GB2469792A publication Critical patent/GB2469792A/en
Priority to ZA2011/07089A priority patent/ZA201107089B/en
Priority to IL215454A priority patent/IL215454A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0906977A 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery Withdrawn GB2469792A (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0906977A GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
MYPI2011005079A MY167918A (en) 2009-04-23 2010-04-23 Composition for use in the sublingual delivery of medicaments to humans
AU2010240653A AU2010240653A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil
MX2011010835A MX2011010835A (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil.
GB1006818.7A GB2469754B (en) 2009-04-23 2010-04-23 Composition for use in the sublingual delivery of medicaments to humans
RU2011139638/15A RU2011139638A (en) 2009-04-23 2010-04-23 SUBLINGUAL PHARMACEUTICAL COMPOSITION CONTAINING NEUTRAL OIL
CN2010800179717A CN102458358A (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical compositions comprising neutral oils
EP10715336A EP2421503A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil
US13/265,825 US20120058158A1 (en) 2009-04-23 2010-04-23 Sublingual Pharmaceutical Composition Comprising a Neutral Oil
JP2012506583A JP2012524771A (en) 2009-04-23 2010-04-23 Pharmaceutical composition for sublingual use containing neutral oil
PCT/GB2010/050671 WO2010122355A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil
BRPI1013539A BRPI1013539A2 (en) 2009-04-23 2010-04-23 sublingual pharmaceutical composition comprising a neutral oil
SG2011073939A SG175160A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil
NZ595467A NZ595467A (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil
CA2756879A CA2756879A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil
ZA2011/07089A ZA201107089B (en) 2009-04-23 2011-09-28 Sublingual pharmaceutical composition comprising a neutral oil
IL215454A IL215454A (en) 2009-04-23 2011-10-02 Sublingual pharmaceutical composition comprising a neutral oil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0906977A GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery

Publications (2)

Publication Number Publication Date
GB0906977D0 true GB0906977D0 (en) 2009-06-03
GB2469792A GB2469792A (en) 2010-11-03

Family

ID=40774840

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0906977A Withdrawn GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
GB1006818.7A Expired - Fee Related GB2469754B (en) 2009-04-23 2010-04-23 Composition for use in the sublingual delivery of medicaments to humans

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1006818.7A Expired - Fee Related GB2469754B (en) 2009-04-23 2010-04-23 Composition for use in the sublingual delivery of medicaments to humans

Country Status (1)

Country Link
GB (2) GB2469792A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2481619B (en) * 2010-06-30 2012-06-20 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
GB201414919D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
GB201419091D0 (en) 2014-10-27 2014-12-10 Camurus Ab Formulations
WO2018169497A1 (en) * 2017-03-17 2018-09-20 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Spray formulation comprising cholecalciferol (vitamin d3) with improved stability
US20220312826A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Liquid mixtures of triglyceride and liquid nicotine
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021909A1 (en) * 1992-04-27 1993-11-11 Vyrex Corporation Improved delivery formulation for lipophilic drugs
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
AU737983B2 (en) * 1996-12-12 2001-09-06 Pharmacia & Upjohn Company An oil composition of dihydropolyprenols
SE9703458D0 (en) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
IT1302682B1 (en) * 1998-10-16 2000-09-29 Formenti Farmaceutici Spa ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENORPHINE
US6617356B2 (en) * 2000-01-03 2003-09-09 Naturally Scientific Inc Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements
GB2380129B (en) * 2001-02-14 2004-08-11 Gw Pharma Ltd Pharmaceutical formulations
CA2567683A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
GB0513984D0 (en) * 2005-07-07 2005-08-17 Teva Pharma Dosage form
US8486972B2 (en) * 2006-01-25 2013-07-16 Insys Therapeutics, Inc. Sublingual fentanyl spray
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
US20070287755A1 (en) * 2006-06-12 2007-12-13 Rosario Ammirante Orally administered compound for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin dificiency
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition

Also Published As

Publication number Publication date
GB2469754A (en) 2010-10-27
GB201006818D0 (en) 2010-06-09
GB2469792A (en) 2010-11-03
GB2469754B (en) 2012-07-18

Similar Documents

Publication Publication Date Title
EP2401012A4 (en) Drug delivery system
PT2398500T (en) Glutathione-based drug delivery system
SG175137A1 (en) Drug delivery composition
IL215222A0 (en) Drug delivery device
IL218839A0 (en) Drug delivery device
IL214379A0 (en) Medicament delivery devices
IL214377A0 (en) Medicament delivery devices
ZA201105032B (en) Medicament delivery devices
IL215219A0 (en) Drug delivery device
EP2493529A4 (en) Medicament delivery device
IL215220A0 (en) Drug delivery device
GB201217611D0 (en) Immediate/delayed drug delivery
EP2482874A4 (en) Medicament delivery device
SG2014007389A (en) Posterior segment drug delivery
ZA201106668B (en) Zoo-technical drug delivery device
EP2398531A4 (en) Implantable drug delivery devices
IL210590A0 (en) Progestin-cotaining drug delivery system
GB201003734D0 (en) Delayed prolonged drug delivery
PL2506909T3 (en) Drug delivery device
PL2493459T3 (en) Ocular drug delivery devices
IL217416A0 (en) Drug delivery delivery device
PL2437736T3 (en) Drug delivery systems
GB201006818D0 (en) Drug delivery
GB0917792D0 (en) Delivery agent
PT2485786T (en) Medicament delivery device

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: LONDONPHARMA LIMITED

Free format text: FORMER OWNER: CALVIN JOHN ROSS

WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)